|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 542.54 USD | -0.44% |
|
-0.19% | +11.50% |
| 06-29 | United Therapeutics Insider Sold Shares Worth $5,167,734, According to a Recent SEC Filing | MT |
| 06-29 | United Therapeutics' LungFX Device Gets FDA Premarket Approval | MT |
| Market Cap | 23.13B 20.25B 18.69B 17.43B 32.85B 2,187B 33.43B 224B 87.03B 1,079B 86.9B 84.96B 3,760B | P/E 2026 * |
20.1x | P/E 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 20.48B 17.93B 16.55B 15.44B 29.09B 1,937B 29.61B 199B 77.08B 956B 76.96B 75.24B 3,330B | EV / Sales 2026 * |
6.31x | EV / Sales 2027 * | 5.2x |
| Free-Float |
53.71% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: United Therapeutics Corporation
| 1 day | -0.39% | ||
| 1 week | -0.19% | ||
| Current month | -2.43% | ||
| 1 month | -0.25% | ||
| 3 months | -7.66% | ||
| 6 months | +9.49% | ||
| Current year | +11.50% |
| 1 week | 535.44 |  | 555.32 |
| 1 month | 532.59 | | 560.97 |
| Current year | 455.63 | | 609.35 |
| 1 year | 272.12 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 1996-06-25 | |
| President | 54 | 2016-06-25 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 2015-03-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 2001-12-31 |
| Chairman | 71 | 1996-06-25 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 2001-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-24 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 06-23 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 06-22 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.44% | -0.19% | +89.07% | +146.11% | 23.13B | |
| -1.56% | +9.59% | +55.64% | +158.71% | 1,097B | |
| -0.91% | +7.36% | +68.04% | +55.07% | 622B | |
| -0.93% | +7.64% | +36.13% | +87.55% | 449B | |
| -1.62% | +6.34% | +29.51% | +24.01% | 334B | |
| -1.38% | +3.75% | +39.33% | +25.04% | 294B | |
| +0.30% | +2.56% | +31.62% | +40.64% | 286B | |
| -0.10% | +2.23% | -28.43% | -42.77% | 213B | |
| +0.21% | +4.08% | +29.35% | +62.67% | 195B | |
| -0.23% | +0.91% | +13.82% | +63.73% | 157B | |
| Average | -0.59% | +6.23% | +36.41% | +62.08% | 366.99B | |
| Weighted average by Cap. | -0.91% | +8.67% | +41.95% | +79.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.25B 2.84B 2.62B 2.45B 4.61B 307B 4.69B 31.47B 12.22B 152B 12.2B 11.93B 528B | 3.7B 3.24B 2.99B 2.79B 5.26B 350B 5.35B 35.9B 13.94B 173B 13.92B 13.61B 602B |
| Net income | 1.26B 1.1B 1.02B 951M 1.79B 119B 1.82B 12.23B 4.75B 58.89B 4.74B 4.64B 205B | 1.48B 1.3B 1.2B 1.12B 2.1B 140B 2.14B 14.35B 5.57B 69.09B 5.56B 5.44B 241B |
| Net Debt | -2.65B -2.32B -2.14B -1.99B -3.76B -250B -3.82B -25.64B -9.96B -123B -9.94B -9.72B -430B | -3.86B -3.38B -3.12B -2.91B -5.49B -365B -5.59B -37.45B -14.54B -180B -14.52B -14.19B -628B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-30 | US$543.52 | -0.26% | 148,498 |
| 26-06-29 | US$544.92 | +0.42% | 420,258 |
| 26-06-26 | US$542.66 | -0.13% | 1,022,244 |
| 26-06-25 | US$543.39 | -1.18% | 285,355 |
| 26-06-24 | US$549.90 | +1.02% | 377,592 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
